Joshua Broghammer, MD
Urology · Kansas City, KSNPI 1689703639
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 99.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $15,059 and has fallen 84.3% since, to $2,368 in 2025. Among urology clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $297.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$24K
- C. R. Bard, Inc. & Subsidiaries$96
- Rochester Medical Corporation$39
- Axonics, Inc.$28
- Stryker$24
- Integra Lifesciences Corporation$19
Across 37 payments — averaging $2003.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$74K
What the payments were for
- Speaking & faculty fees$14,39560%
- Travel & lodging$5,96225%
- Food & beverage$3,73015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 74 | $23,882 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $96 |
| Rochester Medical Corporation | 2 | $39 |
| Axonics, Inc. | 1 | $28 |
| Stryker | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTRA$13,000
- AMS$1,653
- AMS 700$1,531
- AMS 700 CXR RTE KIT$1,419
- GENERAL ERECTILE DYSFUNCTION$374
- AMS 800 Artificial Urinary Sphincter$148
How this compares
$24,087 in reported general payments places this provider in the 90th percentile of 111 urology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 47 | $34,023 |
| Methenamine Hippurate | 27 | $3,468 |
| Trospium Chloride | 38 | $2,048 |
| Clobetasol Propionate | 20 | $1,018 |
| Tamsulosin Hcl | 92 | $951 |
| Nystatin | 20 | $676 |
| Oxybutynin Chloride | 13 | $674 |
| Pentoxifylline | 21 | $593 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $405 |
| Verapamil Hcl | 13 | $205 |
| Finasteride | 23 | $163 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $144 |
| Ciprofloxacin Hcl | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Other urology in Kansas City
- Wilson MolinaKansas City$239K
- Bristol WhilesKansas City$163K
- Jeffrey HolzbeierleinKansas City$78K
- Ahmad El-ArabiKansas City$55K
- David DucheneKansas City$33K
- William ParkerKansas City$20K
- John TaylorKansas City$9K
- Casey KowalikKansas City$8K
- Richard FantusKansas City$7K
- Andrew ArtherKansas City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.